Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CYT003 in patients with allergic asthma uncontrolled on ICS
NCT02087644Phase 2Withdrawn
- Sponsor
- Cytos Biotechnology AG
- Start
- May 2014
- Primary completion
- May 2014
- Countries
- 1
01
Overview
A Phase 2 trial of CYT003-QbG10 in allergic asthma, sponsored by Cytos Biotechnology AG. Planned start May 2014; status: withdrawn.
02
Drugs
CYT003-QbG10
03
Conditions
allergic asthma
Beyond the preview
Go deeper on NCT02087644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02087644.